agilon health, inc. AGL

Q3 FY2026 · ended Sep 30, 2026 · Revenue $1.52B, +5.9% YoY · Filed Nov 4, 2026

agilon health, inc. (AGL) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $1.5 billion and net income of $34.9 million. Free cash flow was $46.6 million. As of Sep 30, 2026 it held $174.4 million in cash and investments and $33.4 million in total debt.

Revenue
$1.52B
+5.9% vs year-ago quarter
Net income
$34.91M
+131.7% vs year-ago quarter
Operating cash flow
$49.87M
+374.7% vs year-ago quarter
Free cash flow
$46.62M
+318.6% vs year-ago quarter
EPS
$1.97
+89.4% vs prior quarter
Dividend per share
None
Shares outstanding
16.80M
-95.9% vs year-ago quarter
Net cash
$140.97M
Q3 FY2026
Operating margin
-2.6%
TTM

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
AGL (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westerville, OH
SEC filer status
Large accelerated filer
SEC CIK
1831097
Former names
Agilon Health Topco, Inc. (until Feb 10, 2021)

Other Services-Misc Health & Allied Services, NEC companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Revenue
$1.5B
$1.5B
$1.4B
$1.6B
$1.4B
Operating income
$24.1M
$11.8M
$4.0M
-$193.8M
-$131.3M
Net income
$34.9M
$18.0M
$48.9M
-$188.9M
-$110.2M
Diluted EPS
$1.97
$1.04
$2.94
—
—
Operating cash flow
$49.9M
-$57.3M
$23.7M
-$20.5M
-$18.2M
Free cash flow
$46.6M
-$60.7M
$20.6M
-$23.5M
-$21.3M
Total assets
$1.6B
$1.6B
$1.5B
$1.3B
$1.6B
Total liabilities
$1.3B
$1.4B
$1.3B
$1.1B
$1.3B
Stockholders' equity
$280.9M
$227.5M
$181.4M
$126.7M
$306.1M
Cash and investments
$174.4M
$107.2M
$140.0M
$173.7M
$171.7M
Total debt
$33.4M
$33.4M
$33.4M
$36.8M
$37.1M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Officer or director change
Jul 22, 2026 Jul 17, 2026
8-K Current report
Shareholder vote results
Jun 3, 2026 Jun 2, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.